Capital Wealth Planning, LLC Biogen Inc. Transaction History

Capital Wealth Planning, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	BUY	$252.44 - $306.72 $193,369 - $234,947	766 New	766 $212,000
Q1 2022 May 11, 2022	SELL	$193.77 - $244.14 $70,338 - $88,622	-363 Reduced 20.95%	1,370 $289,000
Q3 2021 Nov 03, 2021	BUY	$282.99 - $369.05 $38,203 - $49,821	135 Added 8.45%	1,733 $490,000
Q2 2021 Aug 03, 2021	BUY	$259.0 - $414.71 $42,476 - $68,012	164 Added 11.44%	1,598 $553,000
Q1 2021 Apr 19, 2021	BUY	$242.95 - $284.63 $15,548 - $18,216	64 Added 4.67%	1,434 $401,000
Q4 2020 Jan 25, 2021	SELL	$236.26 - $355.63 $47,252 - $71,126	-200 Reduced 12.74%	1,370 $369,000
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $398,595 - $527,869	-1,541 Reduced 49.53%	1,570 $420,000
Q4 2019 Feb 26, 2020	SELL	$220.06 - $304.07 $330,090 - $456,105	-1,500 Reduced 32.53%	3,111 $923,000
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $1 Million - $1.12 Million	4,611 New	4,611 $1.32 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Capital Wealth Planning, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Wealth Planning, LLC with notifications on news.